Pharmaceutical products

Tender description

Invitation to offer for NHS National Pharmaceuticals Transition 2019_1 Offer reference number: CM/PHG/17/5547 Period of Framework Agreement: The total maximum duration of the Framework Agreement to be no more than 34 months potential periods of call-offs under the Framework Agreement: — LSNE: 1.10.2019 to 30.4.2020 (7 months), — CESW: 1.10.2019 to 30.9.2020 (12 months), — NWLN: 1.10.2019 to 28.2.2021 (17 months). Products on the framework include (but are not limited to): — aprepitant, — arsenic, — atazanavir, — atomoxetine, — atovaquone, — bortezomib, — carglumic acid, — clofarabine, — darunavir, — dasatinib, — dexmedetomidine, — everolimus, — fondaparinux, — ganciclovir, — gefitinib, — iloprost, — iron sucrose, — lanthanum, — melphalan, — metaraminol, — miglustat, — nabilone, — olopatadine, — prasugrel, — ritonavir, — solifenacin, — trientine. Details of presentation sizes and volumes are within the tender document set. NHS National Pharmaceuticals Transition 2019_1 Offer reference number: CM/PHG/17/5547 Period of Framework Agreement: the total maximum duration of the Framework Agreement to be no more than 34 months potential periods of call-offs under the Framework Agreement: — LSNE: 1.10.2019 to 30.4.2020 (7 months), — CESW: 1.10.2019 to 30.9.2020 (12 months), — NWLN: 1.10.2019 to 28.2.2021 (17 months). NHS National Pharmaceuticals Transition 2019_1 Offer reference number: CM/PHG/17/5547 Period of Framework Agreement: The total maximum duration of the Framework Agreement to be no more than 34 months potential periods of call-offs under the Framework Agreement: — LSNE: 1.10.2019 to 30.4.2020 (7 months), — CESW: 1.10.2019 to 30.9.2020 (12 months), — NWLN: 1.10.2019 to 28.2.2021 (17 months). NHS National Pharmaceuticals Transition 2019_1 Offer reference number: CM/PHG/17/5547 Period of Framework Agreement: The total maximum duration of the Framework Agreement to be no more than 34 months potential periods of call-offs under the Framework Agreement: LSNE: 1.10.2019 to 30.4.2020 (7 months), CESW: 1.10.2019 to 30.9.2020 (12 months), NWLN: 1.10.2019 to 28.2.2021 (17 months).